Used primarily in pharmaceutical research, 3-(Methylamino)isonicotinic Acid serves as a key intermediate in the synthesis of various bioactive compounds. Its structure is particularly valuable in the development of drugs targeting neurological disorders, where it contributes to the creation of molecules with potential therapeutic effects. Additionally, it finds application in the study of enzyme inhibition, aiding in the discovery of new treatments for diseases influenced by enzymatic activity. Researchers also utilize this compound in the exploration of novel anti-inflammatory and antimicrobial agents, leveraging its chemical properties to enhance drug efficacy and specificity.